UNITED THERAPEUTICS CORP (UTHR) Stock Institutional Trading Activity
UNITED THERAPEUTICS CORP (UTHR) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q1 2026), investors with some of the largest reported share count changes include Sequoia Financial Advisors, Renaissance Technologies LLC, Hancock Classic Value, and First Eagle U.S. Value. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.
Explore more:
- UNITED THERAPEUTICS CORP (UTHR) stock institutional ownership
- UNITED THERAPEUTICS CORP (UTHR) stock insider trading activity
- Stock rankings
| Portfolio quarter | Name | Type | Quantity | Remaining | Reported stock balance |
|---|---|---|---|---|---|
| Q3 2015 | First Eagle U.S. Value | Buy | 121,927 | 548,807 | $72,025 |
| Q3 2015 | Renaissance Technologies LLC | Buy | 55,200 | 866,778 | $113,756 |
| Q2 2015 | First Eagle U.S. Value | Buy | 54,300 | 426,880 | $74,256 |
| Q2 2015 | Renaissance Technologies LLC | Buy | 365,078 | 811,578 | $141,174 |
| Q1 2015 | First Eagle U.S. Value | Buy | 12,400 | 372,580 | $64,246 |
| Q1 2015 | Renaissance Technologies LLC | Buy | 261,262 | 446,500 | $76,992 |
| Q4 2014 | Renaissance Technologies LLC | Buy | 182,860 | 185,238 | $23,986 |
| Q4 2014 | First Eagle U.S. Value | Buy | 98,100 | 360,180 | $46,640 |
| Q3 2014 | Renaissance Technologies LLC | Sell | -250,100 | 2,378 | $306 |
| Q3 2014 | First Eagle U.S. Value | Buy | 262,080 | 262,080 | $33,717 |
| Q2 2014 | Renaissance Technologies LLC | Sell | -35,462 | 252,478 | $22,342 |
| Q1 2014 | Renaissance Technologies LLC | Buy | 63,662 | 287,940 | $27,075 |
| Q4 2013 | Renaissance Technologies LLC | Sell | -216,500 | 224,278 | $25,361 |
| Q3 2013 | Renaissance Technologies LLC | Sell | -149,600 | 440,778 | $34,755 |
| Q2 2013 | Renaissance Technologies LLC | Buy | 590,378 | 590,378 | $38,859 |
Frequently asked questions about UTHR activity
Which institutional owners are buying UTHR?
Institutional owners buying UTHR include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in UTHR activity?
"Buy" means an investor increased their reported position in UTHR compared to the prior reporting period. This reflects growing exposure to UNITED THERAPEUTICS CORP (UTHR) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in UTHR increasing?
Institutional interest in UTHR can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.